Michael Davis

Rule Changes

As of October 2026: Oversees drug review and pilot participation from CDER

A first-in-human drug trial can take up to two years to complete in the United States. The FDA's pilot, part of Operation TrialBlazer, tests a faster path to starting such trials by having sponsors partner with research institutions while the agency reviews application pieces as they are finished.

Updated Oct 4